Skip to main content
Top
Published in: Clinical Rheumatology 6/2015

01-06-2015 | Original Article

Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus

Authors: Arezou Rezaei, Vahid Ziaee, Fatemeh Tahghighi Sharabian, Sara Harsini, Maryam Mahmoudi, Samaneh Soltani, Maryam Sadr, Mohammad Hassan Moradinejad, Yahya Aghighi, Nima Rezaei

Published in: Clinical Rheumatology | Issue 6/2015

Login to get access

Abstract

As abundant types of genetic predisposition and environmental factors seem to be associated with the development of juvenile-onset systemic lupus erythematosus (JSLE), we investigated the gene polymorphisms of two anti-inflammatory cytokines, including interleukin-10 (IL-10) and transforming growth factor-beta (TGF-β), which were previously found to be associated with SLE in adults, in a group of patients with JSLE. We studied a group of 59 Iranian patients with JSLE in comparison with 140 healthy controls and assessed the frequency of alleles, genotypes, and haplotypes of IL-10 and TGF-β single-nucleotide polymorphisms (SNPs) using polymerase chain reaction with sequence-specific primers method. The CA genotype was significantly more frequent at position −592 in IL-10 in patients with juvenile-onset systemic lupus erythematosus than in the controls (P = 0.01). Genotype CC was detected at the same position in 32.7 % of the patients; this frequency was significantly lower than the frequency of 50.7 % recorded in the healthy controls (P = 0.03). The TC haplotype of TGF-β (codon 10, codon 25) was significantly more frequent in the patients with juvenile-onset systemic lupus erythematosus than in the healthy controls (P = 0.02). Nevertheless, these significant associations disappear after Bonferroni correction. Our findings suggest that IL-10 (−1082, −819, −592) and TGF-β (codon 10, codon 25) gene variants may not be associated with the development of JSLE in Iranian population.
Literature
1.
go back to reference Yap DYH, Lai KN (2013) The role of cytokines in the pathogenesis of systemic lupus erythematosus—from bench to bedside. Nephrol 18:243–255CrossRef Yap DYH, Lai KN (2013) The role of cytokines in the pathogenesis of systemic lupus erythematosus—from bench to bedside. Nephrol 18:243–255CrossRef
2.
go back to reference Klein-Gitelman M, Reiff A, Silverman ED (2002) Systemic lupus erythematosus in childhood. Rheum Dis Clin N Am 28:561–577CrossRef Klein-Gitelman M, Reiff A, Silverman ED (2002) Systemic lupus erythematosus in childhood. Rheum Dis Clin N Am 28:561–577CrossRef
3.
go back to reference Tucker L, Menon S, Schaller J, Isenberg D (1995) Adult-and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Rheumatology 34:866–872CrossRef Tucker L, Menon S, Schaller J, Isenberg D (1995) Adult-and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Rheumatology 34:866–872CrossRef
4.
go back to reference Lee P, Lee T-L, Ho M-K, Wong W, Lau Y-L (2007) Recurrent major infections in juvenile-onset systemic lupus erythematosus—a close link with long-term disease damage. Rheumatology 46:1290–1296CrossRefPubMed Lee P, Lee T-L, Ho M-K, Wong W, Lau Y-L (2007) Recurrent major infections in juvenile-onset systemic lupus erythematosus—a close link with long-term disease damage. Rheumatology 46:1290–1296CrossRefPubMed
6.
go back to reference Costallat L, Coimbra A (1993) Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol 12:603–607 Costallat L, Coimbra A (1993) Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol 12:603–607
7.
go back to reference Tsao BP (2004) Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 16:513–521CrossRefPubMed Tsao BP (2004) Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 16:513–521CrossRefPubMed
9.
go back to reference Li MO, Wan YY, Sanjabi S, Robertson A-KL, Flavell RA (2006) Transforming growth factor-β regulation of immune responses. Annu Rev Immunol 24:99–146CrossRefPubMed Li MO, Wan YY, Sanjabi S, Robertson A-KL, Flavell RA (2006) Transforming growth factor-β regulation of immune responses. Annu Rev Immunol 24:99–146CrossRefPubMed
10.
go back to reference Su D-L, Lu Z-M, Shen M-N, Li X, Sun L-Y (2012) Roles of pro-and anti-inflammatory cytokines in the pathogenesis of SLE. BioMed Research International 2012 Su D-L, Lu Z-M, Shen M-N, Li X, Sun L-Y (2012) Roles of pro-and anti-inflammatory cytokines in the pathogenesis of SLE. BioMed Research International 2012
11.
go back to reference Park Y, Lee S, Kim D, Lee J, Lee C, Song C (1997) Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 16:283–288 Park Y, Lee S, Kim D, Lee J, Lee C, Song C (1997) Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 16:283–288
12.
go back to reference Miyake K, Nakashima H, Akahoshi M et al (2002) Genetically determined interferon‐γ production influences the histological phenotype of lupus nephritis. Rheumatology 41:518–524CrossRefPubMed Miyake K, Nakashima H, Akahoshi M et al (2002) Genetically determined interferon‐γ production influences the histological phenotype of lupus nephritis. Rheumatology 41:518–524CrossRefPubMed
13.
go back to reference Ohtsuka K, Gray J, Stimmler M, Horwitz D (1999) The relationship between defects in lymphocyte production of transforming growth factor-β1 in systemic lupus erythematosus and disease activity or severity. Lupus 8:90–94CrossRefPubMed Ohtsuka K, Gray J, Stimmler M, Horwitz D (1999) The relationship between defects in lymphocyte production of transforming growth factor-β1 in systemic lupus erythematosus and disease activity or severity. Lupus 8:90–94CrossRefPubMed
14.
go back to reference Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP (2001) Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 166:3915–3922CrossRefPubMed Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP (2001) Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 166:3915–3922CrossRefPubMed
15.
go back to reference Rood M, Van Krugten M, Zanelli E et al (2000) TNF‐308A and HLA–DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 43:129–134CrossRefPubMed Rood M, Van Krugten M, Zanelli E et al (2000) TNF‐308A and HLA–DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 43:129–134CrossRefPubMed
16.
go back to reference Amirzargar A, Shahram F, Nikoopour E et al (2010) Proinflammatory cytokine gene polymorphisms in Behcet’s disease. Eur Cytokine Netw 21:292–296PubMed Amirzargar A, Shahram F, Nikoopour E et al (2010) Proinflammatory cytokine gene polymorphisms in Behcet’s disease. Eur Cytokine Netw 21:292–296PubMed
17.
go back to reference Mahdaviani SA, Rezaei N, Moradi B, Dorkhosh S, Amirzargar AA, Movahedi M (2009) Proinflammatory cytokine gene polymorphisms among Iranian patients with asthma. J Clin Immunol 29:57–62CrossRefPubMed Mahdaviani SA, Rezaei N, Moradi B, Dorkhosh S, Amirzargar AA, Movahedi M (2009) Proinflammatory cytokine gene polymorphisms among Iranian patients with asthma. J Clin Immunol 29:57–62CrossRefPubMed
18.
go back to reference Rezaei N, Amirzargar AA, Shakiba Y, Mahmoudi M, Moradi B, Aghamohammadi A (2009) Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency. Clin Exp Immunol 155:21–27CrossRefPubMedCentralPubMed Rezaei N, Amirzargar AA, Shakiba Y, Mahmoudi M, Moradi B, Aghamohammadi A (2009) Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency. Clin Exp Immunol 155:21–27CrossRefPubMedCentralPubMed
19.
go back to reference Amirzargar AA, Bagheri M, Ghavamzadeh A et al (2005) Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia. Int J Immunogenet 32:167–171CrossRefPubMed Amirzargar AA, Bagheri M, Ghavamzadeh A et al (2005) Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia. Int J Immunogenet 32:167–171CrossRefPubMed
20.
go back to reference Amirzargar AA, Rezaei N, Jabbari H et al (2006) Cytokine single nucleotide polymorphisms in Iranian patients with pulmonary tuberculosis. Eur Cytokine Netw 17:84–89PubMed Amirzargar AA, Rezaei N, Jabbari H et al (2006) Cytokine single nucleotide polymorphisms in Iranian patients with pulmonary tuberculosis. Eur Cytokine Netw 17:84–89PubMed
21.
go back to reference Ziaee V, Tahghighi F, Moradinejad MH et al (2014) Interleukin-6, interleukin-1 gene cluster and interleukin-1 receptor polymorphisms in Iranian patients with juvenile systemic lupus erythematosus. Eur Cytokine Netw 25:35–40PubMed Ziaee V, Tahghighi F, Moradinejad MH et al (2014) Interleukin-6, interleukin-1 gene cluster and interleukin-1 receptor polymorphisms in Iranian patients with juvenile systemic lupus erythematosus. Eur Cytokine Netw 25:35–40PubMed
22.
go back to reference Mahmoudi M, Tahghighi F, Ziaee V et al (2014) Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus. Int J Immunogenet 41:512–517CrossRefPubMed Mahmoudi M, Tahghighi F, Ziaee V et al (2014) Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus. Int J Immunogenet 41:512–517CrossRefPubMed
23.
go back to reference Khoa PD, Sugiyama T, Yokochi T (2005) Polymorphism of interleukin-10 promoter and tumor necrosis factor receptor II in Vietnamese patients with systemic lupus erythematosus. Clin Rheumatol 24:11–13CrossRefPubMed Khoa PD, Sugiyama T, Yokochi T (2005) Polymorphism of interleukin-10 promoter and tumor necrosis factor receptor II in Vietnamese patients with systemic lupus erythematosus. Clin Rheumatol 24:11–13CrossRefPubMed
24.
go back to reference da Silva HDA, da Silva AP, da Silva HA, Asano NMJ, Maia MdMD, de Souza PRE (2014) Interferon gamma and Interleukin 10 polymorphisms in Brazilian patients with systemic lupus erythematosus. Molecular biology reports 1–8 da Silva HDA, da Silva AP, da Silva HA, Asano NMJ, Maia MdMD, de Souza PRE (2014) Interferon gamma and Interleukin 10 polymorphisms in Brazilian patients with systemic lupus erythematosus. Molecular biology reports 1–8
25.
go back to reference Rianthavorn P, Chokedeemeeboon C, Deekajorndech T, Suphapeetiporn K (2013) Interleukin-10 promoter polymorphisms and expression in Thai children with juvenile systemic lupus erythematosus. Lupus 22:721–726CrossRefPubMed Rianthavorn P, Chokedeemeeboon C, Deekajorndech T, Suphapeetiporn K (2013) Interleukin-10 promoter polymorphisms and expression in Thai children with juvenile systemic lupus erythematosus. Lupus 22:721–726CrossRefPubMed
26.
go back to reference Chong W, Ip W, Wong WH, Lau C, Chan T, Lau Y (2004) Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immun 5:484–492CrossRefPubMed Chong W, Ip W, Wong WH, Lau C, Chan T, Lau Y (2004) Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immun 5:484–492CrossRefPubMed
27.
go back to reference Mok CC, Lanchbury JS, Chan DW, Lau CS (1998) Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 41:1090–1095CrossRefPubMed Mok CC, Lanchbury JS, Chan DW, Lau CS (1998) Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 41:1090–1095CrossRefPubMed
28.
go back to reference Giordano M, Mellai M, Lanceni M et al (2002) Association tests with systemic lupus erythematosus (SLE) of IL10 markers indicate a direct involvement of a CA repeat in the 5′ regulatory region. Genes Immun 3:454–463CrossRefPubMed Giordano M, Mellai M, Lanceni M et al (2002) Association tests with systemic lupus erythematosus (SLE) of IL10 markers indicate a direct involvement of a CA repeat in the 5′ regulatory region. Genes Immun 3:454–463CrossRefPubMed
29.
go back to reference Dijstelbloem HM, Hepkema BG, Kallenberg CG et al (2002) The R-H polymorphism of FCgamma receptor IIa as a risk factor for systemic lupus erythematosus is independent of single-nucleotide polymorphisms in the interleukin-10 gene promoter. Arthritis Rheum 46:1125–1126CrossRefPubMed Dijstelbloem HM, Hepkema BG, Kallenberg CG et al (2002) The R-H polymorphism of FCgamma receptor IIa as a risk factor for systemic lupus erythematosus is independent of single-nucleotide polymorphisms in the interleukin-10 gene promoter. Arthritis Rheum 46:1125–1126CrossRefPubMed
30.
go back to reference Schotte H, Willeke P, Rust S et al (2003) The transforming growth factor-β1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus. Lupus 12:86–92CrossRefPubMed Schotte H, Willeke P, Rust S et al (2003) The transforming growth factor-β1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus. Lupus 12:86–92CrossRefPubMed
31.
go back to reference Wang B, Morinobu A, Kanagawa S, Koshiba M, Hashimoto H, Kumagai S (2007) Transforming growth factor beta 1 gene polymorphism in Japanese patients with systemic lupus erythematosus. Kobe J Med Sci 53:15–23PubMed Wang B, Morinobu A, Kanagawa S, Koshiba M, Hashimoto H, Kumagai S (2007) Transforming growth factor beta 1 gene polymorphism in Japanese patients with systemic lupus erythematosus. Kobe J Med Sci 53:15–23PubMed
32.
go back to reference Lu LY, Cheng HH, Sung PK, Yeh JJ, Shiue YL, Chen A (2004) Single-nucleotide polymorphisms of transforming growth factor-beta1 gene in Taiwanese patients with systemic lupus erythematosus. J Microbiol Immunol Infect = Wei Mian yu gan ran za zhi 37:145–152 Lu LY, Cheng HH, Sung PK, Yeh JJ, Shiue YL, Chen A (2004) Single-nucleotide polymorphisms of transforming growth factor-beta1 gene in Taiwanese patients with systemic lupus erythematosus. J Microbiol Immunol Infect = Wei Mian yu gan ran za zhi 37:145–152
33.
go back to reference Amirzargar AA, Naroueynejad M, Khosravi F et al (2008) Cytokine single nucleotide polymorphisms in Iranian populations. Eur Cytokine Netw 19:104–112PubMed Amirzargar AA, Naroueynejad M, Khosravi F et al (2008) Cytokine single nucleotide polymorphisms in Iranian populations. Eur Cytokine Netw 19:104–112PubMed
34.
go back to reference Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725–1725CrossRefPubMed Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725–1725CrossRefPubMed
35.
36.
go back to reference Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological) 289–300 Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological) 289–300
37.
go back to reference Hoffmann SC, Stanley EM, Cox ED et al (2001) Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-cd3/cd28-stimulated peripheral blood lymphocytes1. Transplantation 72:1444–1450CrossRefPubMed Hoffmann SC, Stanley EM, Cox ED et al (2001) Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-cd3/cd28-stimulated peripheral blood lymphocytes1. Transplantation 72:1444–1450CrossRefPubMed
38.
go back to reference Letterio JJ, Roberts AB (1998) Regulation of immune responses by TGF-β*. Annu Rev Immunol 16:137–161CrossRefPubMed Letterio JJ, Roberts AB (1998) Regulation of immune responses by TGF-β*. Annu Rev Immunol 16:137–161CrossRefPubMed
39.
go back to reference Wahl SM (1994) Transforming growth factor beta: the good, the bad, and the ugly. J Exp Med 180:1587–1590CrossRefPubMed Wahl SM (1994) Transforming growth factor beta: the good, the bad, and the ugly. J Exp Med 180:1587–1590CrossRefPubMed
40.
go back to reference Huggins M, Todd I, Cavers M, Pavuluri S, Tighe P, Powell R (1999) Antibodies from systemic lupus erythematosus (SLE) sera define differential release of autoantigens from cell lines undergoing apoptosis. Clin Exp Immunol 118:322CrossRefPubMedCentralPubMed Huggins M, Todd I, Cavers M, Pavuluri S, Tighe P, Powell R (1999) Antibodies from systemic lupus erythematosus (SLE) sera define differential release of autoantigens from cell lines undergoing apoptosis. Clin Exp Immunol 118:322CrossRefPubMedCentralPubMed
41.
go back to reference Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Inv 101:890CrossRef Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Inv 101:890CrossRef
42.
go back to reference Grainger DJ, Heathcote K, Chiano M et al (1999) Genetic control of the circulating concentration of transforming growth factor type β1. Hum Mol Genet 8:93–97CrossRefPubMed Grainger DJ, Heathcote K, Chiano M et al (1999) Genetic control of the circulating concentration of transforming growth factor type β1. Hum Mol Genet 8:93–97CrossRefPubMed
43.
go back to reference Guarnizo Zuccardi P, Lopez Y, Giraldo M et al (2007) Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus. Tissue Antigens 70:376–382CrossRefPubMed Guarnizo Zuccardi P, Lopez Y, Giraldo M et al (2007) Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus. Tissue Antigens 70:376–382CrossRefPubMed
44.
go back to reference Mosmann TR (1994) Properties and functions of interleukin-10. Adv Immunol 56:1–26PubMed Mosmann TR (1994) Properties and functions of interleukin-10. Adv Immunol 56:1–26PubMed
45.
go back to reference de Waal MR, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209–1220CrossRef de Waal MR, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209–1220CrossRef
46.
go back to reference Rousset F, Garcia E, Defrance T et al (1992) Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci 89:1890–1893CrossRefPubMedCentralPubMed Rousset F, Garcia E, Defrance T et al (1992) Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci 89:1890–1893CrossRefPubMedCentralPubMed
47.
go back to reference Levy Y, Brouet J-C (1994) Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Inv 93:424CrossRef Levy Y, Brouet J-C (1994) Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Inv 93:424CrossRef
48.
go back to reference Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet : Off J Br Soc Histocompatibility Immunogenet 24:1–8CrossRef Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet : Off J Br Soc Histocompatibility Immunogenet 24:1–8CrossRef
49.
go back to reference Kindt S, Van Oudenhove L, Broekaert D et al (2009) Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil : Off J Eur Gastrointest Motil Soc 21:389–398CrossRef Kindt S, Van Oudenhove L, Broekaert D et al (2009) Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil : Off J Eur Gastrointest Motil Soc 21:389–398CrossRef
50.
go back to reference Hua MC, Chao HC, Yao TC, Lai MW, Huang JL (2013) Investigation of interleukin-10 promoter polymorphisms and interleukin-10 levels in children with irritable bowel syndrome. Gut Liver 7:430–436CrossRefPubMedCentralPubMed Hua MC, Chao HC, Yao TC, Lai MW, Huang JL (2013) Investigation of interleukin-10 promoter polymorphisms and interleukin-10 levels in children with irritable bowel syndrome. Gut Liver 7:430–436CrossRefPubMedCentralPubMed
51.
go back to reference Suárez A, López P, Mozo L, Gutiérrez C (2005) Differential effect of IL10 and TNFα genotypes on determining susceptibility to discoid and systemic lupus erythematosus. Ann Rheum Dis 64:1605–1610CrossRefPubMedCentralPubMed Suárez A, López P, Mozo L, Gutiérrez C (2005) Differential effect of IL10 and TNFα genotypes on determining susceptibility to discoid and systemic lupus erythematosus. Ann Rheum Dis 64:1605–1610CrossRefPubMedCentralPubMed
52.
go back to reference Crawley E, Woo P, Isenberg DA (1999) Single nucleotide polymorphic haplotypes of the interleukin‐10 5′ flanking region are not associated with renal disease or serology in caucasian patients with systemic lupus erythematosus. Arthritis Rheum 42:2017–2018CrossRefPubMed Crawley E, Woo P, Isenberg DA (1999) Single nucleotide polymorphic haplotypes of the interleukin‐10 5′ flanking region are not associated with renal disease or serology in caucasian patients with systemic lupus erythematosus. Arthritis Rheum 42:2017–2018CrossRefPubMed
53.
go back to reference Lazarus M, Hajeer A, Turner D et al (1997) Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 24:2314–2317PubMed Lazarus M, Hajeer A, Turner D et al (1997) Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 24:2314–2317PubMed
54.
go back to reference Sung Y-K, Park B, Shin H, Kim L, Kim S-Y, Bae S-C (2006) Interleukin-10 gene polymorphisms are associated with the SLICC/ACR Damage Index in systemic lupus erythematosus. Rheumatology 45:400–404CrossRefPubMed Sung Y-K, Park B, Shin H, Kim L, Kim S-Y, Bae S-C (2006) Interleukin-10 gene polymorphisms are associated with the SLICC/ACR Damage Index in systemic lupus erythematosus. Rheumatology 45:400–404CrossRefPubMed
55.
go back to reference Hirankarn N, Wongpiyabovorn J, Hanvivatvong O et al (2006) The synergistic effect of FC gamma receptor IIa and interleukin‐10 genes on the risk to develop systemic lupus erythematosus in Thai population. Tissue Antigens 68:399–406CrossRefPubMed Hirankarn N, Wongpiyabovorn J, Hanvivatvong O et al (2006) The synergistic effect of FC gamma receptor IIa and interleukin‐10 genes on the risk to develop systemic lupus erythematosus in Thai population. Tissue Antigens 68:399–406CrossRefPubMed
56.
go back to reference Lin Y, Wan L, Huang C et al (2010) L-10 and TNF-alpha promoter polymorphisms in susceptibility to systemic lupus erythematosus in Taiwan. Clin Exp Rheumatol 28:318–324PubMed Lin Y, Wan L, Huang C et al (2010) L-10 and TNF-alpha promoter polymorphisms in susceptibility to systemic lupus erythematosus in Taiwan. Clin Exp Rheumatol 28:318–324PubMed
57.
go back to reference Rosado S, Rua-Figueroa I, Vargas J et al (2008) Interleukin‐10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands. Int J Immunogenet 35:235–242CrossRefPubMed Rosado S, Rua-Figueroa I, Vargas J et al (2008) Interleukin‐10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands. Int J Immunogenet 35:235–242CrossRefPubMed
Metadata
Title
Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus
Authors
Arezou Rezaei
Vahid Ziaee
Fatemeh Tahghighi Sharabian
Sara Harsini
Maryam Mahmoudi
Samaneh Soltani
Maryam Sadr
Mohammad Hassan Moradinejad
Yahya Aghighi
Nima Rezaei
Publication date
01-06-2015
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 6/2015
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-2877-2

Other articles of this Issue 6/2015

Clinical Rheumatology 6/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.